USA - NASDAQ:CMND - CA1850534027 - Common Stock
The current stock price of CMND is 1.07 USD. In the past month the price increased by 3.92%. In the past year, price decreased by -15.19%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 44.63 | 682.12B | ||
JNJ | JOHNSON & JOHNSON | 17.88 | 430.62B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 14.01 | 244.70B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.91 | 238.36B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 16.62 | 228.83B | ||
MRK | MERCK & CO. INC. | 10.12 | 194.59B | ||
PFE | PFIZER INC | 6.98 | 134.55B | ||
SNY | SANOFI-ADR | 10.23 | 111.29B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.43 | 88.13B | ||
GSK | GSK PLC-SPON ADR | 8.89 | 80.63B | ||
ZTS | ZOETIS INC | 22.99 | 63.37B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.79 | 46.52B |
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
CLEARMIND MEDICINE INC
101-1220 West 6Th Avenue
Vancouver BRITISH COLUMBIA CA
Employees: 0
Phone: 16042601566
The current stock price of CMND is 1.07 USD. The price increased by 0.94% in the last trading session.
The exchange symbol of CLEARMIND MEDICINE INC is CMND and it is listed on the Nasdaq exchange.
CMND stock is listed on the Nasdaq exchange.
CLEARMIND MEDICINE INC (CMND) has a market capitalization of 5.76M USD. This makes CMND a Nano Cap stock.
CLEARMIND MEDICINE INC (CMND) currently has 0 employees.
CLEARMIND MEDICINE INC (CMND) has a support level at 1.05 and a resistance level at 1.16. Check the full technical report for a detailed analysis of CMND support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CMND does not pay a dividend.
CLEARMIND MEDICINE INC (CMND) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.2).
The outstanding short interest for CLEARMIND MEDICINE INC (CMND) is 2.72% of its float. Check the ownership tab for more information on the CMND short interest.
ChartMill assigns a technical rating of 6 / 10 to CMND. When comparing the yearly performance of all stocks, CMND turns out to be only a medium performer in the overall market: it outperformed 46.52% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to CMND. CMND has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months CMND reported a non-GAAP Earnings per Share(EPS) of -1.2. The EPS increased by 91.77% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -75.3% | ||
ROE | -173.75% | ||
Debt/Equity | 0 |